ATE449344T1 - Quantifizierung des carnitinspiegels bei dialyse- patienten - Google Patents

Quantifizierung des carnitinspiegels bei dialyse- patienten

Info

Publication number
ATE449344T1
ATE449344T1 AT03770386T AT03770386T ATE449344T1 AT E449344 T1 ATE449344 T1 AT E449344T1 AT 03770386 T AT03770386 T AT 03770386T AT 03770386 T AT03770386 T AT 03770386T AT E449344 T1 ATE449344 T1 AT E449344T1
Authority
AT
Austria
Prior art keywords
carnitine
deficiency
methods
diagnosing
quantifying
Prior art date
Application number
AT03770386T
Other languages
English (en)
Inventor
Donald Chace
Gianfranco Fornasini
Original Assignee
Sigma Tau Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Pharmaceuticals Inc filed Critical Sigma Tau Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE449344T1 publication Critical patent/ATE449344T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173845Amine and quaternary ammonium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
AT03770386T 2002-09-23 2003-09-23 Quantifizierung des carnitinspiegels bei dialyse- patienten ATE449344T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/252,115 US7011977B2 (en) 1999-01-30 2002-09-23 Quantification of carnitine levels in dialysis patients
PCT/US2003/029821 WO2004026114A2 (en) 2002-09-23 2003-09-23 Quantification of carnitine levels in dialysis patients

Publications (1)

Publication Number Publication Date
ATE449344T1 true ATE449344T1 (de) 2009-12-15

Family

ID=32029013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03770386T ATE449344T1 (de) 2002-09-23 2003-09-23 Quantifizierung des carnitinspiegels bei dialyse- patienten

Country Status (11)

Country Link
US (1) US7011977B2 (de)
EP (1) EP1587406B1 (de)
AT (1) ATE449344T1 (de)
AU (1) AU2003278872A1 (de)
CY (1) CY1110607T1 (de)
DE (1) DE60330185D1 (de)
DK (1) DK1587406T3 (de)
ES (1) ES2336787T3 (de)
PT (1) PT1587406E (de)
SI (1) SI1587406T1 (de)
WO (1) WO2004026114A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7333894B2 (en) * 2002-01-31 2008-02-19 Sigma-Tau Pharmaceuticals, Inc. Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
EP1862797A4 (de) * 2005-03-16 2009-09-16 Ajinomoto Kk Vorrichtung, verfahren, system und programm zur bewertung biologischer zustände, vorrichtung, verfahren und programm zur erzeugung einer bewertungsfunktion sowie aufzeichnungsmedium
WO2016013115A1 (ja) * 2014-07-25 2016-01-28 株式会社 リージャー 希釈生体試料成分の分析方法
GB201916046D0 (en) * 2019-11-04 2019-12-18 Amazentis Sa Diagnostic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5316917A (en) * 1992-11-04 1994-05-31 Duke University Automated analysis of free l-carnitine and total short-chain acylcarnitine
US6258605B1 (en) * 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
US6455321B1 (en) * 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US6335369B1 (en) * 2000-01-19 2002-01-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6429230B1 (en) * 2000-01-19 2002-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis

Also Published As

Publication number Publication date
EP1587406B1 (de) 2009-11-18
US20030129762A1 (en) 2003-07-10
EP1587406A4 (de) 2007-01-03
EP1587406A2 (de) 2005-10-26
US7011977B2 (en) 2006-03-14
AU2003278872A8 (en) 2004-04-08
SI1587406T1 (sl) 2010-03-31
DK1587406T3 (da) 2010-03-15
ES2336787T3 (es) 2010-04-16
DE60330185D1 (de) 2009-12-31
PT1587406E (pt) 2010-02-23
WO2004026114A3 (en) 2004-08-19
CY1110607T1 (el) 2015-04-29
WO2004026114A2 (en) 2004-04-01
AU2003278872A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
EP2319941A3 (de) Methode und vorrichtung zur korrelation von biomarker produktmengen mit krankheiten
BR112017021305A2 (pt) dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva
NO20053976L (no) Online kilderekonstruksjon for EEG/MEG og ECG/MCG.
WO2007062225A3 (en) Test substrate handling apparatus
CY1110607T1 (el) Ποσοτικοποιηση επιπεδων καρνιτινης σε ασθενεις που υποβαλλονται σε αιμοκαθαρση
WO2008014132A3 (en) Combination analyte measurement device and method of use
TW200736606A (en) Gated voltammetry
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
WO2007126444A3 (en) Analyte monitoring
EP1978361A3 (de) Verfahren zur Korrektur eines Blutglucose-Assay-Bias mittels der durch ein Glucose-Hämoglobin-A1C-Kombinationssystem bestimmten Hämoglobinkonzentration und Vorrichtungen dafür
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
HK1109787A1 (en) Analytical method and instrument
UA103474C2 (ru) Устройство для мониторинга места доступа к сосудистой системе и оборудование для экстракорпорального лечения крови с устройством для мониторинга места доступа к сосудистой системе
WO2008097773A8 (en) Methods and devices for diagnosis of appendicitis
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
ATE487939T1 (de) Analytisches system und verfahren zu dessen betrieb
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient
WO2005039487A3 (en) Method for early detection of ovarian cancer
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
JP2003207495A5 (de)
AU2003294932A1 (en) Method for the detection of cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1587406

Country of ref document: EP